We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03220477
Brief Title: Pembrolizumab (Immunotherapy Drug) in Combination With Guadecitabine and Mocetinostat (Epigenetic Drugs) for Patients With Advanced Lung Cancer.

First Submitted : July 14, 2017
First Submitted that Met QC Criteria : July 14, 2017
First Posted : July 18, 2017

Last Update Submitted that Met QC Criteria : August 1, 2022
Last Update Posted : August 2, 2022